LewinE.Involution of the parathyroid glands after renal transplantation.Curr Opin Nephrol Hypertens2003; 12: 363–71.
2.
TraindlO., LangleF., ReadingS.. Secondary hyperparathyroidism and acute tubular necrosis following renal transplantation.Nephrol Dial Transplant1993; 8: 73–6.
3.
MessaP.G., SindiciC., CannellaG.Persistent hyperparathyroidism after renal transplantation.Kidney Int1998; 54: 1704–13.
4.
LoboP.I., CortezM.S., StevensonW.. Normocalcemic hyperparathyroidism associated with relatively low 1,25 vitamin D levels post renal transplant can be successfully treated with oral calcitriol.Clin Transplant1995; 9: 277–81.
5.
TorresA., RodriguezA.P., ConcepcionM.T.. Parathyroid function in long term transplant patients: importance of pretransplant PTH concentrations.Nephrol Dial Transplant1998; 13(Suppl 3): 94–97.
6.
MontalbanM., De FranciscoA.L., MarinosoM.L., ZubimendiJ.A., AriasM.Bone disease in long term adult kidney transplant patients with normal renal function.Kidney Int2003; 8(suppl): S1129–32.
7.
ParfittA.M.Hypercalcemic hyperparathyroidism following renal transplantation: differential diagnosis, management and implications for cell population control in the parathyroid gland.Miner Electrolyte Metab1999; 8: 92–112.
8.
ChoncholM., WüthrichR.P.Potential future uses of calciomimetics with chronic kidney disease.Nephrol Dial Transplant2008; 1(Suppl 1Il calciomimetico nell'iperparatiroidismo primitivo e se): 36–40.
9.
CaravacaF., FernandezM.A., Ruiz-Calero. Effects of oral phosphorus supplementation on mineral metabolism of renal transplant recipients.Nephrol Dial Transplant1998; 13: 2605–11.
10.
BorchhardtK., SulzbacherI., FodingerM.. Low-turnover bone disease in hypercalcemic hyperparathyroidism after kidney transplantation.Am J Transplant2007; 7: 2515–21.
11.
EwersB., GasbjergA., MoelgaardC.. Vitamin D status in kidney transplant patients: need for intensified routine supplementation.AM J Clin Nutr2008; 87: 431–7.
12.
JosephonM.A., SchummL.P., ChiuMY. Calcium and calcitriol prophylaxis attenuates postransplant bone loss.Transplantation2004; 78: 1233–6.
13.
ReginsterJ.Y., LecartM.P., SarletN., DefraigneJ.O.Alpha-calcidol in prevention of glucocorticoid-induced osteoporosis.Calcif Tissue Int1999; 65: 328–31.
14.
De SevauxR.G., HoitsmaA.J., CortstensF.H., WetzelsJ.F.Treatment of vitamina D and calcium reduces bone loss after renal transplantation: a randomized study.J Am Soc Nephrol2002; 13: 1608–12.
15.
KunzendorfU., KramerK.B., ArnsW.. Bone disease after renal transplantation.Nephrol Dial Transplant2008; 23: 450–58.
16.
RojasE., CarliniRg, ClescaP.. The pathogenesis of osteodystrophy after renal transplantation as detected by early alterations in bone remodeling.Kidney Int2003; 63: 1915–23.
17.
SchwarzA., RustienG., MerkelS.. Decreased renal transplant function after parathyroidectomy.Nephrol Dial Transplant2007; 22: 584–91.
18.
RostaingL., Moreau-GaudryX., BaronE.. Changes in blood pressure and renal function following subtotal parathyroidectomy in renal transplant patients presenting with persistent hypercalcemic hyperparathyroidism.Clin Nephrol1997; 47: 248–55.
19.
EndlichK., MassfelderT., HelwigJ.Vascular effects of parathyroid hormone and parathyroid hormone related protein in the split hydronephrotic rat kidney.J Physiol1995; 483: 481–90.
20.
MassfelderT., ParekhN., EndlichK.. Effect of intrarenally infused parathyroid hormone-related protein on renal blood flow and glomerular filtration rate in the anaesthetized rat.Br J Pharmacol1996; 118: 1995–2000.
21.
JespersenB., RandlovA., AbrahamsenJ.. Effects of PTH on blood pressure, renal function, hormones, in essential hypertension: the altered pattern of reactivity may counteract raised blood pressure.Am J Hypertens1997; 10: 1356–67.
22.
SerraA.L., SchwarzA.A., WickF.H.. Successful treatment of hypercalcemia with cinacalcet in renal transplant recipients with persistent hyperparathyroidism.Nephrol Dial Transplant2005; 20: 1315–19.
23.
SerraA.L., SavocaR., HuberA.R.. Effective control of persistent hyperparathyroidism with cinacalcet in renal allografts recipients.Nephrol Dial Transplant2006; 22: 577–83.
24.
KruseA.E., EisenbergeU., FreyF.J.. The calcimimetic cinacalcet normalizes serum calcium in renal transplant patients with persistent hyperparathyroidism.Nephrol Dial Transplant2005; 20: 1311–14.
25.
LecaN., LafttaviM., GundrooA.. Early and severe hyperparathyroidism associated with hypercalcemia after renal transplant treated with cinacalcet.Am J Transplant2006; 6: 2391–95.
26.
SwarcI., ArgilesA., GarrigueV.. Cinacalcet chloride is efficient and safe in renal transplant recipients with post transplant hyperparathyroidism.Transplantation2006; 82: 675–80.
27.
ApostolouT., DamianouL., KotsievV.. Treatment of severe hypercalcemia due to refractory hyperparathyroidism in renal transplant patients with the calcimimetic agent cinacalcet.Clin Nephrol2006; 65: 374–77.
28.
ApostolouT., KolliaK., DamianouL.. Hypercalcemia due to resistant hyperparathyroidism in renal transplant patients treated with the calcimimetic agent cinacalcet.Transplant Proc2006; 38: 3514–16.
29.
SrinivasT.R., ScholdJ.D., WomerK.L.. Improvement in hypercalcemia with cinacalcet after kidney transplantation.Clin J Am Soc Nephrol2006; 1: 323–26.
30.
El-AmmJ.M., DoshiM.D., SinghA.. Preliminary experience with cinacalcet use in persistent secondary hyperparathyroidism after kidney transplantation.Transplan-tation2007; 83: 546–49.
31.
SerraA.L., BraunS.C., StarkeA.. Pharmacokinetics and pharmacodynamics of Cinacalcet in patients with hyperparathyroidism after renal transplantation.Am J Transplant2008; 8: 803–10.
32.
BoulangerH., HaymannJ.P., FouquerayB.. Therapeutic failure of cinacalcet in a renal transplant patient presenting hyperparathyroidism with severe hypercalcemia.Nephrol Dial Transplant2005; 20: 2865.
33.
SerraA.L., WuhrmannC., WuthrichtR.Phosphatemic effect of Cinacalcet in Kidney Transplant Recipients with persistent Hyperparathyroidism.Am J Kidney Dis2008; 6: 1151–57.
34.
KruseA.E., EisenbergerU., FelixJ.F., MoauptM.G.Effect of cinacalcet cessation in renal- transplant recipients with persistent hyperparathyroidism.Nephrol Dial Transplant2007; 22: 2362–65.
35.
JeanG., ChazotC., CharraB.Six cases of successful cinacalcet cessation in hemodialysis patients treated for secondary hyperparathyroidism.Nephrol Dial Transplant2007; 22: 577–583.
36.
PalFalck, VetheN.T., AsbergA.. Cinacalcet's effect on pharmacokinetics of tacrolimus, cyclosporine and mycophenolate in renal transplant recipients.Nephrol Dial Transplant2008; 23: 1048–53.
37.
MaassE., MuellerG.A., HellerT., KoziolekM.J.Decrease in serum Tacrolimus level and rise in S creatinine under late addition of Cinacalcet in a Renal Transplant Recipient with Hyperparathyroidism: A case report.Transplantation Proceedings2007; 39: 3468–70.
38.
EspositoL., RostaingL., GenneroI., MehrenbergerM., DurandD., KamarN.Hypercalciuria induced by high dose of cinacalcet in a renal transplant recipient.Clin Nephrol2007; 4: 245–48.
39.
BorchhardtK.A., HeinzlH., MayerwögerE., HörlW.H., HaasM., Sunder-PlassmannG.Cinacalcet Increase Calcium Excretion in Hypercalcemic Hyperparathyroidism After Kidney Transplantation.Transplantation2008; 7: 919–24.
40.
LienY.H., SilvaA.L., WhittmannD.Effects of cinacalcet on bone mineral density in patients with secondary hyperparathyroidism.Nephrol Dial Transplant2005; 20: 1232–37.
41.
BerguaC., TorregrosaJ.V., FusterD., DalmauA.G., OppheneimerF., CampistolJ.M.Effect of Cinacalcet on Hypercalcemia and Bone Mineral Density in Renal Transplanted Patients with Secondary Hyperparathyroidism.Transplantation2008; 3: 413–17.
42.
KamarN., GenneroI., SpataruL.. Pharmacodynamic effects of cinacalcet after kidney transplantation: once versus twice daily dose.Nephrol Dial Transplant2008; 23: 3720–26.
43.
MeolaM., PetrucciI., BarsottiG.Long term treatment with cinacalcet and conventional therapy reduces parathyroid hyperplasia in severe secondary hyperparathyroidism.Nephrol Dial Transplant2009; 3: 982–89.
